Founder and CEO, Entrada ESL
Erin Janklow brings an MBA from Babson College, three years experience in Product, Brand, and Responsible Travel at TripAdvisor, and four years running an English business in Rome, Italy, where she developed and refined elements of Entrada’s TalkBack Method. She is pleased to be a Halcyon Fellow (2.7% acceptance) and a Project Entrepreneur Grantee (0.7% acceptance). Entrada was listed as one of the Top 10 Startups in Washington DC for 2018, and as one of the Top 8 “Makers to Watch” in DC for 2019. After gaining fluency in Italian while studying abroad, she created a method to teach learners living in the country where the language is spoken, and has since taught herself Spanish employing only Entrada’s TalkBack® Method.
CEO, Astarte Medical
As co-founder and CEO of Astarte Medical, Tracy leverages her experience in entrepreneurship and nearly two decades as an early stage venture capital investor. Tracy previously co-founded Astarte Ventures, an early stage investment firm focused exclusively on investing in companies with technologies to support women’s and children’s health and wellbeing. This passive portfolio includes eight companies supporting this market focus. It was through the efforts associated with Astarte Ventures, Tracy and her co-founders came together to form Astarte Medical to dramatically impact health outcomes in the first 1000 days of life, from conception through age 2.
Prior to Astarte, Tracy served as general partner at Battelle Ventures and focused on investments in health & life sciences, as well as emerging energy technologies. Tracy led the firm’s investments in NuPathe (NASDAQ: PATH; acquired by Teva Pharmaceuticals for $140 million), BioNano Genomics (NASDAQ: BNGO), Micro Interventional Devices, and SmartSynch (sold to Itron for $100 million). While at Battelle Ventures, Tracy co-founded NellOne Therapeutics, a biotechnology company focused on soft tissue regeneration.
In 2014, Tracy to co-found FedIMPACT, LLC in 2014, a commercialization enterprise to identify and launch technologies from federal laboratories. Having successfully spun-out four companies in just 18 months with over $5M of funding, FedIMPACT was acquired by IP Group, plc in December 2016.
Tracy received her BS in Accounting and International Business from New York University and her MBA at Columbia Business School in Finance.
RoseAnn B. Rosenthal
President & CEO, Ben Franklin Technology Partners of Southeastern PA
RoseAnn B. Rosenthal is President, CEO and member of the Board of Directors of Ben Franklin Technology Partners of Southeastern Pennsylvania (Ben Franklin). Praised by regional, national and international leaders as a pioneer of public-private partnerships and an invaluable resource for innovation-focused investment and growth in Greater Philadelphia, Rosenthal has over forty-five years of experience in economic development, business investment, and regional planning. With a current portfolio of over 200 technology companies, Rosenthal has led Ben Franklin since 1996, growing its reputation and impact through innovative partnerships and a solid track record of seeding hundreds of southeastern Pennsylvania’s technology leaders across all areas of technology.
Rosenthal helped design and launch the region’s Health Care Innovation Collaborative, an open innovation model unifying universities, corporations, investors, healthcare providers and insurers in development of new solutions; and catalyzed the development and launch of ImpactPHL, a regional alliance focused on growth of the Greater Philadelphia’s impact economy.
In 2018, Rosenthal received honors from the National Venture Capital Association, the Community College of Philadelphia Foundation, Temple University for her innovation in investing, technology commercialization, and development of new possibilities for Philadelphia and its citizens.
In February, she led Ben Franklin to launch the GO Philly Fund, a regional venture fund that allows private investors to invest in a broad variety of early-stage technology-focused enterprises located in the
Greater Philadelphia region. In partnership with EPAM, the innovative fund leverages blockchain technology as part of its innovative fund raising and capital management strategy, facilitating individual investor participation from around the world.
Under Rosenthal’s guidance, Ben Franklin has grown to create more than 32,000 technology-focused jobs in the Philadelphia region, created from the more than 2000 companies the organization has helped form. These companies have enabled the growth of more than $5.1 billion in activity to Southeastern Pennsylvania’s economy.